Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Fields, Meira
1999.
Role of trace elements in coronary heart disease.
British Journal of Nutrition,
Vol. 81,
Issue. 2,
p.
85.
Fox, Paul L
Mazumder, Barsanjit
Ehrenwald, Eduardo
and
Mukhopadhyay, Chinmay K
2000.
Ceruloplasmin and cardiovascular disease.
Free Radical Biology and Medicine,
Vol. 28,
Issue. 12,
p.
1735.
Rayssiguier, Y.
and
Mazur, A.
2002.
Trace Elements in Man and Animals 10.
p.
97.
Lind, Peter
Hedblad, Bo
Hultberg, Björn
Stavenow, Lars
Janzon, Lars
and
Lindgärde, Folke
2003.
Risk of Myocardial Infarction in Relation to Plasma Levels of Homocysteine and Inflammation-Sensitive Proteins: A Long-Term Nested Case-Control Study.
Angiology,
Vol. 54,
Issue. 4,
p.
401.
Galhardi, Cristiano M.
Diniz, Yeda S.
Faine, Luciane A.
Rodrigues, Hosana G.
Burneiko, Regina C.M.
Ribas, Bartolome O.
and
Novelli, Ethel L.B.
2004.
Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction.
Food and Chemical Toxicology,
Vol. 42,
Issue. 12,
p.
2053.
Uriu-Adams, Janet Y.
and
Keen, Carl L.
2005.
Copper, oxidative stress, and human health.
Molecular Aspects of Medicine,
Vol. 26,
Issue. 4-5,
p.
268.
Awadallah, Samir M.
Hamad, Mawieh
Jbarah, Ibrahim
Salem, Nuha M.
and
Mubarak, Mohammad S.
2006.
Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease.
Clinica Chimica Acta,
Vol. 365,
Issue. 1-2,
p.
330.
Shukla, Nilima
Maher, John
Masters, Joseph
Angelini, Gianni D
and
Jeremy, Jamie Y
2006.
Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?.
Atherosclerosis,
Vol. 187,
Issue. 2,
p.
238.
Ziakas, Antonios
Gavrilidis, Stavros
Souliou, Efthimia
Giannoglou, George
Stiliadis, Ioannis
Karvounis, Haralambos
Efthimiadis, George
Mochlas, Sotirios
Vayona, M. Arvanitidou
Hatzitolios, Apostolos
Savopoulos, Christos
Pidonia, Ifigenia
and
Parharidis, George
2009.
Ceruloplasmin is a Better Predictor of the Long-Term Prognosis Compared with Fibrinogen, CRP, and IL-6 in Patients with Severe Unstable Angina.
Angiology,
Vol. 60,
Issue. 1,
p.
50.
Kasprzak, Magdalena
Iskra, Maria
Majewski, Wacław
and
Wielkoszyński, Tomasz
2009.
Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs.
Clinical Biochemistry,
Vol. 42,
Issue. 1-2,
p.
50.
Makedou, Kali G.
Mikhailidis, Dimitri P.
Makedou, Areti
Iliadis, Stavros
Kourtis, Anargyros
Vavatsi-Christaki, Norma
and
Papageorgiou, Georgios E.
2009.
Lipid Profile, Low-Density Lipoprotein Oxidation and Ceruloplasmin in the Progeny of Families with a Positive History of Cardiovascular Diseases and/or Hyperlipidemia.
Angiology,
Vol. 60,
Issue. 4,
p.
455.
Iwata, Tomoyuki
Kantarci, Alpdogan
Yagi, Motohiko
Jackson, Tina
Hasturk, Hatice
Kurihara, Hidemi
and
Van Dyke, Thomas E.
2009.
Ceruloplasmin Induces Polymorphonuclear Leukocyte Priming in Localized Aggressive Periodontitis.
Journal of Periodontology,
Vol. 80,
Issue. 8,
p.
1300.
Kim, Hyun-Jung
Yoo, Hyun-Syuk
Kim, Pan-Kyeom
Kim, Mi-Ryung
Lee, Hyup-Woo
and
Kim, Chan-Wha
2011.
Comparative analysis of serum proteomes of patients with cardiovascular disease.
Clinical Biochemistry,
Vol. 44,
Issue. 2-3,
p.
178.
Wilson Tang, W.H.
Wu, Yuping
Hartiala, Jaana
Fan, Yiying
Stewart, Alexandre F.R.
Roberts, Robert
McPherson, Ruth
Fox, Paul L.
Allayee, Hooman
and
Hazen, Stanley L.
2012.
Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk.
Arteriosclerosis, Thrombosis, and Vascular Biology,
Vol. 32,
Issue. 2,
p.
516.
Mocchegiani, Eugenio
Costarelli, Laura
Giacconi, Robertina
Piacenza, Francesco
Basso, Andrea
and
Malavolta, Marco
2012.
Micronutrient (Zn, Cu, Fe)–gene interactions in ageing and inflammatory age-related diseases: Implications for treatments.
Ageing Research Reviews,
Vol. 11,
Issue. 2,
p.
297.
Xu, Yifei
Lin, Haiyan
Zhou, Ying
Cheng, Gang
and
Xu, Geng
2013.
Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients.
Mediators of Inflammation,
Vol. 2013,
Issue. ,
p.
1.
Dadu, Razvan T.
Dodge, Rhiannon
Nambi, Vijay
Virani, Salim S.
Hoogeveen, Ron C.
Smith, Nicholas L.
Chen, Fengju
Pankow, James S.
Guild, Cameron
Tang, W.H. Wilson
Boerwinkle, Eric
Hazen, Stanley L.
and
Ballantyne, Christie M.
2013.
Ceruloplasmin and Heart Failure in the Atherosclerosis Risk in Communities Study.
Circulation: Heart Failure,
Vol. 6,
Issue. 5,
p.
936.
Hammadah, Muhammad
Fan, Yiying
Wu, Yuping
Hazen, Stanley L.
and
Tang, W.H. Wilson
2014.
Prognostic Value of Elevated Serum Ceruloplasmin Levels in Patients With Heart Failure.
Journal of Cardiac Failure,
Vol. 20,
Issue. 12,
p.
946.
Grammer, T. B.
Kleber, M. E.
Silbernagel, G.
Pilz, S.
Scharnagl, H.
Lerchbaum, E.
Tomaschitz, A.
Koenig, W.
and
März, W.
2014.
Copper, ceruloplasmin, and long-term cardiovascular and total mortality (The Ludwigshafen Risk and Cardiovascular Health Study).
Free Radical Research,
Vol. 48,
Issue. 6,
p.
706.
Mocchegiani, Eugenio
Costarelli, Laura
Giacconi, Robertina
Malavolta, Marco
Basso, Andrea
Piacenza, Francesco
Ostan, Rita
Cevenini, Elisa
Gonos, Efstathios S.
and
Monti, Daniela
2014.
Micronutrient–gene interactions related to inflammatory/immune response and antioxidant activity in ageing and inflammation. A systematic review.
Mechanisms of Ageing and Development,
Vol. 136-137,
Issue. ,
p.
29.